{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:15:15Z","timestamp":1783682115134,"version":"3.55.0"},"reference-count":49,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2026,1,14]]},"published-print":{"date-parts":[[2026,3]]},"DOI":"10.2967\/jnmt.125.271678","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:15:25Z","timestamp":1770750925000},"page":"3-9","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative Amyloid Brain Imaging: A Literature Review of the Centiloid Scale in Alzheimer Disease Evaluation"],"prefix":"10.2967","volume":"54","author":[{"given":"Abtin","family":"Doroudinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026030412502062000_54.1.3.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"2026030412502062000_54.1.3.2","doi-asserted-by":"crossref","first-page":"103765","DOI":"10.1016\/j.nicl.2025.103765","article-title":"A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research","volume":"46","author":"Iaccarino","year":"2025","journal-title":"Neuroimage Clin."},{"key":"2026030412502062000_54.1.3.3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8850"},{"key":"2026030412502062000_54.1.3.4","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00587-5"},{"key":"2026030412502062000_54.1.3.5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamaneurol.2025.2218","article-title":"Concordance between amyloid-PET quantification and real-world visual reads","volume":"82","author":"Zeltzer","year":"2025","journal-title":"JAMA Neurol."},{"key":"2026030412502062000_54.1.3.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.09.001"},{"key":"2026030412502062000_54.1.3.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268119"},{"key":"2026030412502062000_54.1.3.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.2008"},{"key":"2026030412502062000_54.1.3.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171595"},{"key":"2026030412502062000_54.1.3.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.1353"},{"key":"2026030412502062000_54.1.3.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-018-0456-7"},{"key":"2026030412502062000_54.1.3.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.148981"},{"key":"2026030412502062000_54.1.3.13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.dadm.2018.12.008","article-title":"Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies","volume":"11","author":"Su","year":"2019","journal-title":"Alzheimers Dement (Amst)."},{"key":"2026030412502062000_54.1.3.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3749-6"},{"key":"2026030412502062000_54.1.3.15","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00836-1"},{"key":"2026030412502062000_54.1.3.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117593"},{"key":"2026030412502062000_54.1.3.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119527"},{"key":"2026030412502062000_54.1.3.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70252-2"},{"key":"2026030412502062000_54.1.3.19","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0485-18.2018"},{"key":"2026030412502062000_54.1.3.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05784-y"},{"key":"2026030412502062000_54.1.3.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.03.014"},{"key":"2026030412502062000_54.1.3.22","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00807-6"},{"key":"2026030412502062000_54.1.3.23","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.9"},{"key":"2026030412502062000_54.1.3.24","doi-asserted-by":"crossref","first-page":"e14321","DOI":"10.1002\/alz.14321","article-title":"Overview of Alzheimer\u2019s Disease Neuroimaging Initiative and future clinical trials","volume":"21","author":"Weiner","year":"2025","journal-title":"Alzheimers Dement."},{"key":"2026030412502062000_54.1.3.25","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911170"},{"key":"2026030412502062000_54.1.3.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4669"},{"key":"2026030412502062000_54.1.3.27","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14336"},{"key":"2026030412502062000_54.1.3.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.01.028"},{"key":"2026030412502062000_54.1.3.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263195"},{"key":"2026030412502062000_54.1.3.30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","article-title":"Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2","volume":"13","author":"Mormino","year":"2017","journal-title":"Alzheimers Dement."},{"key":"2026030412502062000_54.1.3.31","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2020.12134"},{"key":"2026030412502062000_54.1.3.32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww027"},{"key":"2026030412502062000_54.1.3.33","doi-asserted-by":"crossref","first-page":"578753","DOI":"10.3389\/fneur.2020.578753","article-title":"Quantitative evaluation of 18F-flutemetamol PET in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study","volume":"11","author":"Matsuda","year":"2020","journal-title":"Front Neurol."},{"key":"2026030412502062000_54.1.3.34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive associations of vascular risk and \u03b2-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain study","volume":"75","author":"Rabin","year":"2018","journal-title":"JAMA Neurol."},{"key":"2026030412502062000_54.1.3.35","doi-asserted-by":"crossref","first-page":"e70712","DOI":"10.1002\/alz.70712","article-title":"Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data","volume":"21","author":"Luo","year":"2025","journal-title":"Alzheimers Dement."},{"key":"2026030412502062000_54.1.3.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30159-X"},{"key":"2026030412502062000_54.1.3.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238477"},{"key":"2026030412502062000_54.1.3.38","doi-asserted-by":"publisher","DOI":"10.1007\/S00259-020-05120-2\/FIGURES\/1"},{"key":"2026030412502062000_54.1.3.39","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jamaneurol.2025.3869","article-title":"Posttreatment amyloid levels and clinical outcomes following donanemab for early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"82","author":"Lu","year":"2025","journal-title":"JAMA Neurol."},{"key":"2026030412502062000_54.1.3.40","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"2026030412502062000_54.1.3.41","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/alz.13677","article-title":"Harmonizing florbetapir and PiB PET measurements of cortical A\u03b2 plaque burden using multiple regions-of-interest and machine learning techniques: an alternative to the Centiloid approach","volume":"20","author":"Chen","year":"2024","journal-title":"Alzheimers Dement."},{"key":"2026030412502062000_54.1.3.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04596-x"},{"key":"2026030412502062000_54.1.3.43","doi-asserted-by":"crossref","unstructured":"La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12:eaau5732.","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"2026030412502062000_54.1.3.44","doi-asserted-by":"crossref","unstructured":"Farrell JS, Lovett-Barron M, Klein PM, et al. Supramammillary regulation of locomotion and hippocampal activity. Science. 2021;374:1492\u20131496.","DOI":"10.1126\/science.abh4272"},{"key":"2026030412502062000_54.1.3.45","doi-asserted-by":"crossref","unstructured":"Villemagne VL, Pike KE, Ch\u00e9telat G, et al. Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181\u2013192.","DOI":"10.1002\/ana.22248"},{"key":"2026030412502062000_54.1.3.46","doi-asserted-by":"crossref","unstructured":"Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u2013367.","DOI":"10.1016\/S1474-4422(13)70044-9"},{"key":"2026030412502062000_54.1.3.47","doi-asserted-by":"crossref","unstructured":"Matsuda H, Okita K, Motoi Y, et al. Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study. Ann Nucl Med. 2022;36:1039\u20131049.","DOI":"10.1007\/s12149-022-01792-y"},{"key":"2026030412502062000_54.1.3.48","doi-asserted-by":"crossref","unstructured":"Mintun MA, Lo AC, Duggan Evans C, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384:1691\u20131704.","DOI":"10.1056\/NEJMoa2100708"},{"key":"2026030412502062000_54.1.3.49","doi-asserted-by":"crossref","unstructured":"Pemberton HG, Collij LE, Heeman F, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49:3508\u20133528.","DOI":"10.1007\/s00259-022-05784-y"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.271678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:50:37Z","timestamp":1772657437000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.271678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.2967\/jnmt.125.271678"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.271678","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}